- On December 31, 2007 during President Bush's second term
- On March 6, 2009, very early in President Obama's first term, which was their lowest point due to the spillover effects resulting from the 2008 financial meltdown, and
- also on the most recent date February 4, 2014.
The historical common stock prices of these companies were obtained from the following two excellent internet resources.... Google Finance and MarketWatch Big Charts.
These 13 US Major Drug Manufacturing Companies had their average stock prices increase by a massive 1,128% from March 6, 2009 to today February 5, 2014, driven by a spectacular 13,318% stock price increase registered by Keryx Biopharmaceuticals, which is having positive results in developing an oral compound for treating chronic kidney disease.
Clearly, the investors in and employees of a clear majority of these 13 largest US Major Drug Manufacturing Companies must be very pleased with the impact of actions taken by both the Obama Administration and the US Fed to successfully rescue the US economy from its extremely weakened state.
Below here are the stock market prices of each of these 13 largest US Major Drug Manufacturing Companies on February 4, 2014, on March 6, 2009, and on December 31, 2007:
| Market | Market | ||||||
| Price | Price | ||||||
| % | % | ||||||
| Change | Change | ||||||
| Market | Market | Market | 3-6-09 | 12-31-07 | |||
| Price | Price | Price | to | to | |||
| US Major Drug Manufacturers | 2-5-14 | 3-6-09 | 12-31-07 | 2-5-14 | 3-6-09 | ||
| Keryx Biopharmaceuticals | New York | NY | 14.76 | 0.11 | 8.40 | 13318% | -99% |
| Neurocrine Biosciences | San Diego | CA | 16.57 | 3.21 | 4.54 | 416% | -29% |
| Rockwell Medical | Wixom | MI | 10.44 | 2.89 | 7.18 | 261% | -60% |
| Bristol-Myers Squibb | New York | NY | 48.54 | 18.35 | 26.52 | 165% | -31% |
| Pfizer | New York | NY | 30.65 | 12.73 | 22.73 | 141% | -44% |
| Merck | Whitehouse Station | NJ | 53.53 | 22.74 | 58.11 | 135% | -61% |
| Provectus Biopharmaceuticals | Knoxville | TN | 1.88 | 0.88 | 1.72 | 114% | -49% |
| NanoViricides | West Haven | CT | 4.60 | 2.38 | 1.37 | 93% | 74% |
| Eli Lilly | Indianapolis | IN | 52.72 | 27.98 | 53.39 | 88% | -48% |
| Johnson & Johnson | New Brunswick | NJ | 87.28 | 47.97 | 66.70 | 82% | -28% |
| Rigel Pharmaceuticals | South San Francisco | CA | 2.94 | 4.40 | 25.39 | -33% | -83% |
| SIGA Technologies | New York | NY | 3.02 | 4.66 | 3.08 | -35% | 51% |
| Star Scientific | Glen Allen | VA | 0.69 | 2.79 | 0.80 | -75% | 251% |
| Average % Change all 13 | 1128% | -12% |
In addition, there were another 14 US Major Drug Manufacturing Companies whose common stocks first started trading subsequent to March 6, 2009 and which also now have Market Capitalizations of at least $100 mil each.
The below chart shows the stock market prices on the most recent date February 5, 2014 and also on the close of the first trading date of the 14 additional US Major Drug Manufacturing Companies with current Total Market Capitalizations of at least $100 mil each and whose common stocks first started trading subsequent to March 6, 2009:
| Closing | ||||||||
| Month | Price | |||||||
| Of | On | |||||||
| Market | First | First | ||||||
| Price | Trading | Trading | % | |||||
| Major Drug Manufacturers | HQs | 2-5-14 | Date | Date | Change | |||
| Intercept Pharmaceuticals | New York | NY | 297.46 | Oct 2012 | 19.40 | 1433% | ||
| Pacira Pharmaceuticals | Parsippany | NJ | 63.90 | Feb 2011 | 7.02 | 810% | ||
| Impax Laboratories | Hayward | CA | 22.29 | Mar 2009 | 5.84 | 282% | ||
| Kythera Biopharmacuticals | Calabasas | CA | 45.02 | Oct 2012 | 19.79 | 127% | ||
| Tetraphase Pharmaceuticals | Watertown | MA | 14.06 | Mar 2013 | 7.00 | 101% | ||
| Karyopharm Therapeutics | Natick | MA | 31.74 | Nov 2013 | 16.05 | 98% | ||
| Retrophin | New York | NY | 9.96 | Feb 2013 | 5.25 | 90% | ||
| Aerie Pharmaceuticals | Bedminster | NJ | 17.13 | Oct 2013 | 10.61 | 61% | ||
| AbbVie | North Chicago | IL | 47.73 | Dec 2012 | 35.00 | 36% | ||
| Horizon Pharma | Deerfield | IL | 9.91 | Jul 2011 | 9.15 | 8% | ||
| Ampio Pharmaceuticals | Greenwood Village | CO | 8.30 | May 2011 | 7.95 | 4% | ||
| Zogenix | San Diego | CA | 4.14 | Nov 2010 | 3.98 | 4% | ||
| Alimera Sciences | Alpharetta | GA | 6.37 | Apr 2010 | 11.00 | -42% | ||
| KaloBios Pharmaceuticals | South San Francisco | CA | 2.68 | Jan 2013 | 8.00 | -67% | ||
| Average 23 Mos % Increase all 14 | 211% |
Yeah, these 14 additional US Major Drug Manufacturing Companies whose common stocks first started trading subsequent to March 6, 2009 experienced a very robust 211% average stock price increase for the very short 23 month average period through February 5, 2014.
When you combine the above two charts, 24 of these 27 largest US Major Drug Manufacturing Companies are headquartered in US States voting for Barack Obama in both Presidential Elections.
With both of these exceptional results, I think it is very reasonable to conclude that the US Major Drug Manufacturers have performed exceedingly well during the Obama Administration.
Also, these US Major Drug Manufacturing Companies have flat out thrived under the Affordable Care Act. Wise investors have moved up their common stock market prices smartly in anticipation of many more US citizens being covered by insurance and by Medicaid Expansion.
